课题基金 / 基金详情

Regulation of Hippocampal Neurogenesis by Antidepressants

Regulation of Hippocampal Neurogenesis by Antidepressants
抗抑郁药对海马神经发生的调节
批准号:
8111695
负责人:
IRWIN LUCKI
金额:
$39.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2014-05-31

项目摘要

项目成果

IRWIN LUCKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal examines how the regulation of adult neurogenesis produced by repeated antidepressant drug treatment in mice may contribute to behavioral recovery from stress and depression. Major depressive disorder results from convergent underlying genetic predispositions and exposure to environmental stress. Evidence for increases of neurogenesis in the adult dentate gyrus of the hippocampus is a model for changes in neuroplasticity that emerge with chronic treatment with antidepressant drugs and serve as a model for the production of therapeutic effects. Most studies have measured the effects of antidepressants using rodents under routine housing conditions and have ignored the critical role of genetics and stress in contributing to drug treatment effects. We have identified a mouse strain (MRL/MpJ) that shows larger increases in neurogenesis following chronic fluoxetine. Also, the addition of stress hormones augments the effects of fluoxetine on neurogenesis in a non-responder mouse strain (C57BL/6). The central hypothesis of this grant proposal is that genetic predispositions and stress produce a critical role for revealing the effects of chronic antidepressant treatments on hippocampal neurogenesis. The use of flow cytometry as a technique to measure neurogenesis rapidly developed by this laboratory will enable completion of the large number of studies required for investigation of the pharmacology of neurogenesis. The primary goals of this proposal are: 1) demonstrate the critical role of exposure to corticosterone (CORT) in augmenting responses to chronic treatment with antidepressant drugs on neurogenesis and behavior in a responder and non-responder mouse strain; 2) show whether environmental stress plays a similar role in causing antidepressant drugs to alter neurogenesis and behavior; and 3) determine whether hippocampal BDNF serves as a mechanism underlying the production these effects by chronic antidepressant drug treatments. PUBLIC HEALTH RELEVANCE: This project examines the convergent role of genetic predispositions and exposure to environmental stress in mouse models regulating the effects of chronic antidepressant drug treatments on hippocampal neurogenesis and behavior. Major depression is an important public health problem because of its severe economic impact and contribution to morbidity from other medical disorders. The results of this project will contribute to identifying mechanisms of vulnerability and resilience to stress and lead to the discovery of novel and more effective antidepressant treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kappa Receptor Antagonists as Rapid Acting Antidepressants
Kappa Receptor Antagonists as Rapid Acting Antidepressants
Buprenorphine for Depression and Anxiety
  • 批准号:
    8451367
  • 项目类别:
  • 资助金额:
    $38.4万
  • 财政年份:
    2012
  • 负责人:
    IRWIN LUCKI
  • 依托单位:
Buprenorphine for Depression and Anxiety
  • 批准号:
    8627211
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2012
  • 负责人:
    IRWIN LUCKI
  • 依托单位:
海外基金